NASDAQ: DNAY - Codex DNA, Inc.

Yield per half year: +6.95%
Dividend yield: 0.00%
Sector: Healthcare

Codex DNA, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.27 -100% 0 0%
P/S 1.68 33.44 -94.98%
P/BV 0.66 4.64 -85.79%
P/FCF -1.03 42.53 -102.42%
Ev/Ebitda -0.24 -17.68 -98.64%
Ev/S 0.5619 22.59 -97.51%
Ev/FCF -0.3026 47.55 -100.64%
E/P -1.31 0.0182 -7297.8%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-233.33 -14.2 1542.76% -248.15 -5.97%
ROE -67.7 9.78 -792.04%
ROA -29.63 0.33 -9077.46%
ROIC -109.21 7.63 -1530.51%
ROS -251.43 -26.41 851.89%
ROCE 0 14.55 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.4367 -3.87 -88.72% -0.4119 +6.04%
Nеt Debt/Ebitda 0 -4.24 -100%
Debt/Ratio 0.7966 0.1853 329.93%
Debt/Equity 0 1.61 -100%
Debt/Net Income -0.4053 10.06 -104.03%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5351 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2368 -100%
Average dividend growth 0 1.48 -100%
Average percentage for 5 years 0 0.4863 -100%
Average percentage for payments 0 43.64 -100%
Difference from average difference in sector -0.5351

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
200 30.62 553.17%
Growth impulse Ebitda in 5 years 77.54 -17.42 -545.12%
Growth impulse Net Income in 5 years 429.99 -52.26 -922.79%
Growth impulse FCF in 5 years 143.75 -31.68 -553.76%
Growth impulse EPS in 5 years 612.41 -61.82 -1090.63%
IP Score
5.08/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription